Vaccine adjuvants: mechanisms and platforms

T Zhao, Y Cai, Y Jiang, X He, Y Wei, Y Yu… - Signal transduction and …, 2023 - nature.com
Adjuvants are indispensable components of vaccines. Despite being widely used in
vaccines, their action mechanisms are not yet clear. With a greater understanding of the …

CpG DNA as a vaccine adjuvant

C Bode, G Zhao, F Steinhagen, T Kinjo… - Expert review of …, 2011 - Taylor & Francis
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs trigger cells
that express Toll-like receptor 9 (including human plasmacytoid dendritic cells and B cells) …

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer

J Scheiermann, DM Klinman - Vaccine, 2014 - Elsevier
Synthetic oligonucleotides (ODN) that express unmethylated “CpG motifs” trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …

Unleashing the potential of NOD-and Toll-like agonists as vaccine adjuvants

C Maisonneuve, S Bertholet… - Proceedings of the …, 2014 - National Acad Sciences
Innate immunity confers an immediate nonspecific mechanism of microbial recognition
through germ line-encoded pattern recognition receptors (PRRs). Of these, Toll-like …

Use of defined TLR ligands as adjuvants within human vaccines

MS Duthie, HP Windish, CB Fox… - Immunological …, 2011 - Wiley Online Library
Our improved understanding of how innate immune responses can be initiated and how
they can shape adaptive B‐and T‐cell responses is having a significant impact on vaccine …

CpG oligonucleotides as vaccine adjuvants

N Kayraklioglu, B Horuluoglu, DM Klinman - DNA Vaccines: Methods and …, 2021 - Springer
CpG Oligonucleotides (ODN) are immunomodulatory synthetic oligonucleotides specifically
designed to stimulate Toll-like receptor 9. TLR9 is expressed on human plasmacytoid …

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

F Wegmann, KH Gartlan, AM Harandi… - Nature …, 2012 - nature.com
Protection against mucosally transmitted infections probably requires immunity at the site of
pathogen entry 1, yet there are no mucosal adjuvant formulations licensed for human use …

The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system

AL Engel, GE Holt, H Lu - Expert review of clinical pharmacology, 2011 - Taylor & Francis
Toll-like receptor (TLR) ligation activates both the innate and adaptive immune systems, and
plays an important role in antiviral and anti-tumor immunity. Therefore, a significant amount …

Dysregulation of human Toll-like receptor function in aging

AC Shaw, A Panda, SR Joshi, F Qian, HG Allore… - Ageing research …, 2011 - Elsevier
Studies addressing immunosenescence in the immune system have expanded to focus on
the innate as well as the adaptive responses. In particular, aging results in alterations in the …

The use of toll-like receptor agonists in HIV-1 cure strategies

JT Martinsen, JD Gunst, JF Højen, M Tolstrup… - Frontiers in …, 2020 - frontiersin.org
Toll-like receptors (TLRs) are a family of pattern recognition receptors and part of the first
line of defense against invading microbes. In humans, we know of 10 different TLRs, which …